| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $81.3M | -32.0% |
| SG&A Expense | $41.5M | -16.6% |
| Operating Income | -$122.8M | +27.5% |
| Pre-tax Income | -$2.8M | +98.4% |
| Income Tax | $2.0M | -12.7% |
| Net Income | -$3.4M | +97.9% |
| EPS (Basic) | -$0.05 | +98.1% |
| EPS (Diluted) | -$0.05 | +98.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.7M | +184.1% |
| Short-term Investments | $162.1M | +86.9% |
| Accounts Receivable | $10.9M | +41.1% |
| Current Assets | $215.7M | +60.8% |
| Total Assets | $325.6M | +17.5% |
| Current Liabilities | $78.1M | -1.8% |
| Long-term Debt | $87.9M | -46.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.1M | +22.0% |
| Capital Expenditures | $65K | -60.6% |
| Investing Cash Flow | $164.5M | +100.1% |
| Financing Cash Flow | -$42.2M | -167.1% |
| Free Cash Flow | -$116.2M | +22.0% |
| -$121.2M |
| +33.6% |